Advertisement

Topics

Lonza Group Ltd Company Profile

06:19 EDT 25th June 2018 | BioPortfolio

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality-minded production. Creative thinking, dedicated staff and sound resources are the strengths that Lonza relies on for further growth. Our people are the key to success – they have extensive expertise in multidisciplinary project management, integrating the wishes and know-how of our customers at every stage.

Location

Muenchensteinerstrasse 38
Basel
CH-4002
Switzerland

Contact

Phone: 41 61 316 81 11
Fax: 41 61 316 91 11
Email: info@lonza.com


News Articles [544 Associated News Articles listed on BioPortfolio]

Denali, Lonza collaborate on biologics for neurodegenerative diseases

Denali Therapeutics Inc. is collaborating with Lonza Group Ltd. to advance Denali’s biologic pipeline of neurodegenerative disease compounds through all stages of development and manufacturing.

New Lonza biotech facility in Pearland changes hands

Zeller Realty Group has purchased the Lonza Viral Therapy Facility, a 276,770-square-foot biotechnology facility at 14905 Kirby Drive in Pearland, from Pinchal & Co. HFF handled the transaction.

Lonza Reports Positive Start to 2018

Lonza had a positive start to 2018 led by the businesses along the healthcare continuum. The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, has shown a strong ...

Lonza to Showcase Its Latest Solutions for Enhanced QC Testing and Transfection at SLAS2018

From 3-7 February 2018, Lonza will be exhibiting at SLAS2018, the annual show hosted by the Society for Laboratory Automation and Screening. At Booth 534 Lonza will showcase how its automated QC testi...

Lonza Opens Cell and Gene Therapy Facility in Pearland, TX

Lonza today will officially open what it says is the world’s largest dedicated cell-and-gene-therapy facility in the Houston suburb of Pearland, TX. Executives from Lonza will join other dignita...

Lonza opens world’s largest gene therapy manufacturing plant in Texas

Swiss drug manufacturer Lonza has opened a ‘state-of-the-art’ cell and gene therapy manufacturing facility, the Lonza Houston Center of Excellence....Read More... The post Lonza opens world’s la...

BRIEF — New center is world’s largest dedicated cell and gene manufacturing unit, says Lonza

Swiss pharmaceutical and biotech ingredient supplier Lonza is showing plenty of faith in what it calls…

Lonza posts double-digit organic sales growth

Swiss pharmaceutical and biotech ingredient supplier Lonza today announced its record-breaking 2017 full-year…

PubMed Articles [1799 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Nephroprotective Effect of Zingerone against CCl-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

The protective effects of Zingerone against CCl induced nephrotoxicity in Swiss albino mice via modulation of metabolizing enzyme, oxidative stress, inflammatory cytokines, and apoptosis. The biochemi...

Clinical Trials [3703 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

the Influence of Sleep Improvement Through Different Methods on Patients in ICU

In the research, we enroll 120 postoperative patients in the ICU and they will be assigned to four group: the eye patch group, the Dexmedetomidine(DEX) group, the eye patch+DEX group and t...

Companies [1620 Associated Companies listed on BioPortfolio]

LONZA Biologics plc

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality...

Lonza Group Ltd

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality...

Lonza Inc.

Basel, 17.05.2006 - Lonza Group announces the acquisition of assets which comprise Larex, Inc.’s Larch Arabinogalactan business. This strategic acquisition includes among other things, intellectual...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Lonza Group Ltd" on BioPortfolio

We have published hundreds of Lonza Group Ltd news stories on BioPortfolio along with dozens of Lonza Group Ltd Clinical Trials and PubMed Articles about Lonza Group Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lonza Group Ltd Companies in our database. You can also find out about relevant Lonza Group Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record